Type of participants | Follow up period | Type of treatment | Type of main outcome | N | Country | Ref. no. |
---|---|---|---|---|---|---|
Adverse effect | ||||||
Psychiatric inPT | 4, 8-12W | Multimodal psychotherapy | Global severity Index and depression severity | 480 | Germany | 24 |
Substance users | 10+15W | Motivational intervention | Response to treatment | 260 | USA | 25 |
Psychiatric outPT | 12-21 W | Short-term psychotherapy | Psychiatric symptomatology | 251 | Canada | 26 |
Hemodialysis outPT | 5Y | Hemodialysis therapy | All cause mortality | 230 | Japan | 27 |
Hemodialysis outPT | 6M | Hemodialysis therapy | Depression deterioration | 230 | Japan | 28 |
OutPT with possible | 6Y | Pyschotherapy | Recovery from depression | 121 | Finland | 29 |
Veterans with military sexual trauma. | 7W | Specialized residential treatment | Symptom persistence | 175 | USA | 30 |
Women taking elective surgical abortion | 2M | Surgical abortion | Re-experience and avoidance | 140 | Netherlands | 31 |
OutPT with functional gastrointestinal disorders | 6M | Unspecified treatment | Response to treatment | 112 | Italy | 32 |
PT taking implantable cardioverter defibrillator | 2-5.5 Y | ICD placement | Posttraumatic stress | 107 | Switzerland | 33 |
Eating disorder PT | 3Y | Drug treatment and psychotherapy | PT’ compliance and types of treatments | 102 | France | 34 |
Eating disorder PT | 3Y | Unspecified treatment | Response to treatment | 102 | France | 35 |
OutPT with major depression | 1Y | Unspecified treatment | Response to treatment | 86 | Finland | 36 |
PT with asthma | 2Y | Unspecified treatment | Emargency room visits and QOL (SF-36) | 76 | Spain | 37 |
OutPT with major depression | 10W | Antidepressant | Reduction of depression severity | 65 | Turkey | 38 |
PT with type 1 Diabetes | 8W | Inpatient treatment | Decrease in HbA1c | 64 | Belgium | 39 |
Alcohol abuser | 15W | Inpatient treatment | Maintaining abstinent | 46 | France | 40 |
PT with somatoform and anxiety disorder | 2Y | Inpatient treatment | Symptom persistence | 30 | Austria | 41 |
Beneficial effect | ||||||
Cancer PT | 6M | Multicomponent psychological intervention | Pain | 104 | Italy | 42 |
PT taking in vitro fertilization | 6M | In vitro fertilization | Delivery of a living infant | 81 | Greece | 43 |
Colorectal cancer PT | 3Y | Surgery | QOL (SF-36) | 60 | Italy | 44 |
Ulcerative colotis PT | 17M | Pelvic pouch surgery | Psychosocial adjustment | 53 | Sweden | 45 |
Gynecologic PT | 1M | Laparoscopy or laparotomy | QOL (SF-36) | 40 | Italy | 46 |
No association | ||||||
Psychiatric inPT | 4, 8-12W | Psychodynamic group therapy | Global severity Index and depression severity | 297 | Germany | 47 |
OutPT with unexplained physical symptom | 6W | Unspecified treatment | Symptom persistence | 127 | Netherland | 48 |
Pregnant women | 1M | Unspecified | Depression development | 149 | Italy | 49 |
PT with psoriasis | 6M | Cognitive behavioral therapy | Response to treatment | 80 | UK | 50 |
Obese outPT | 8M | Behavioral program | Compliance and weight loss | 68 | Italy | 51 |
InPT taking respiratory rehabilitation | 4W | Respiratory rehabilitation | Functional recovery | 60 | Italy | 52 |
Panic disorder PT | 6M | CBT | Response to treatment | 55 | Switzerland | 53 |
Psychiatric consultation outPT | 1Y | Psychotherapy | PT’s compliance | 54 | Finland | 54 |
OCD inPT | 31-139 D | Multimodal CBT | Response to treatment | 42 | Germany | 55 |
Bulmia nervosa PT | 10W | Drug treatment | Symptom improvements | 41 | England | 56 |
CFS outPT | 18M | Unspecified treatment | Symptom improvements | 40 | Netherland | 57 |
OutPT with psoriasis | 3M | Delmatological treatment | Response to treatment | 40 | France | 58 |
OCD inPT | 6Y | Inpatient treatment | OCD deteriotion | 34 | Switzerland | 59 |
Schizophrenia outPT | 1Y | Appropriate treatment | Symptom improvements | 29 | Italy | 60 |
Eating disorder inPT | 1Y | Psychoeducation | Dietary restraint | 19 | Switzerland | 61 |